Literature DB >> 9512562

An improved PCR-mutagenesis strategy for two-site mutagenesis or sequence swapping between related genes.

R D Kirsch1, E Joly.   

Abstract

The QuikChangeTM protocol is one of the simplest and fastest methods for site-directed mutagenesis, but introduces mutations at only one site at a time, and requires two HPLC-purified complementary oligonucleotides. Here, we describe that this method can be used with non-overlapping oligonucleotides. By doing this, two separate sites can be mutagenised simultaneously, or money can be saved by using a second 'standard' oligonucleotide. By a further modification, we have also used the QuikChangeTM approach to exchange DNA sequences between closely related genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512562      PMCID: PMC147442          DOI: 10.1093/nar/26.7.1848

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  18 in total

1.  Two versatile eukaryotic vectors permitting epitope tagging, radiolabelling and nuclear localisation of expressed proteins.

Authors:  O Georgiev; J P Bourquin; M Gstaiger; L Knoepfel; W Schaffner; C Hovens
Journal:  Gene       Date:  1996-02-12       Impact factor: 3.688

2.  An efficient PCR mutagenesis strategy without gel purification [correction of "purificiation"] step that is amenable to automation.

Authors:  B Séraphin; S Kandels-Lewis
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

3.  PCR mutagenesis: treatment of the megaprimer with mung bean nuclease improves yield.

Authors:  D Chattopadhyay; T Raha; D Chattopadhyay
Journal:  Biotechniques       Date:  1997-06       Impact factor: 1.993

4.  Genes in two MHC class I regions control recognition of a single rat NK cell allodeterminant.

Authors:  C Naper; B Rolstad; K Wonigeit; G W Butcher; J T Vaage
Journal:  Int Immunol       Date:  1996-11       Impact factor: 4.823

5.  "Megaprimer" method of PCR-based mutagenesis: the concentration of megaprimer is a critical factor.

Authors:  A M Smith; K P Klugman
Journal:  Biotechniques       Date:  1997-03       Impact factor: 1.993

6.  A rapid and efficient method for site-directed mutagenesis using one-step overlap extension PCR.

Authors:  A Urban; S Neukirchen; K E Jaeger
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

7.  PCR-mediated recombination and mutagenesis. SOEing together tailor-made genes.

Authors:  R M Horton
Journal:  Mol Biotechnol       Date:  1995-04       Impact factor: 2.695

8.  Gene splicing by overlap extension.

Authors:  R M Horton; S N Ho; J K Pullen; H D Hunt; Z Cai; L R Pease
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

9.  Megaprimer method for in vitro mutagenesis using parallel templates.

Authors:  M Upender; L Raj; M Weir
Journal:  Biotechniques       Date:  1995-01       Impact factor: 1.993

10.  The rat MHC haplotype RT1c expresses two classical class I molecules.

Authors:  E Joly; L Leong; W J Coadwell; C Clarkson; G W Butcher
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

View more
  86 in total

1.  Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis.

Authors:  A Sawano; A Miyawaki
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

2.  Site-specific protein modification to identify the MutL interface of MutH.

Authors:  Grischa H Toedt; Ravi Krishnan; Peter Friedhoff
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

3.  Identification, characterization, and epitope mapping of human monoclonal antibody J19 that specifically recognizes activated integrin α4β7.

Authors:  JunPeng Qi; Kun Zhang; Qiao Zhang; Yi Sun; Ting Fu; GuoHui Li; JianFeng Chen
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

4.  Distance variations between active sites of H(+)-pyrophosphatase determined by fluorescence resonance energy transfer.

Authors:  Yun-Tzu Huang; Tseng-Huang Liu; Yen-Wei Chen; Chien-Hsien Lee; Hsueh-Hua Chen; Tsu-Wei Huang; Shen-Hsing Hsu; Shih-Ming Lin; Yih-Jiuan Pan; Ching-Hung Lee; Ian C Hsu; Fan-Gang Tseng; Chien-Chung Fu; Rong-Long Pan
Journal:  J Biol Chem       Date:  2010-05-28       Impact factor: 5.157

5.  Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.

Authors:  Veronique Daniëls; Renée Vancraenenbroeck; Bernard M H Law; Elisa Greggio; Evy Lobbestael; Fangye Gao; Marc De Maeyer; Mark R Cookson; Kirsten Harvey; Veerle Baekelandt; Jean-Marc Taymans
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

6.  Type II restriction endonuclease R.KpnI is a member of the HNH nuclease superfamily.

Authors:  Matheshwaran Saravanan; Janusz M Bujnicki; Iwona A Cymerman; Desirazu N Rao; Valakunja Nagaraja
Journal:  Nucleic Acids Res       Date:  2004-11-23       Impact factor: 16.971

7.  Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.

Authors:  Linos Vandekerckhove; Frauke Christ; Bénédicte Van Maele; Jan De Rijck; Rik Gijsbers; Chris Van den Haute; Myriam Witvrouw; Zeger Debyser
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  TCL/RhoJ Plasma Membrane Localization and Nucleotide Exchange Is Coordinately Regulated by Amino Acids within the N Terminus and a Distal Loop Region.

Authors:  Karly L Ackermann; Rebecca R Florke; Shannon S Reyes; Brooke R Tader; Michael J Hamann
Journal:  J Biol Chem       Date:  2016-09-22       Impact factor: 5.157

9.  High-affinity insulin binding: insulin interacts with two receptor ligand binding sites.

Authors:  Linda Whittaker; Caili Hao; Wen Fu; Jonathan Whittaker
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

10.  A novel strategy for the identification of protein-DNA contacts by photocrosslinking and mass spectrometry.

Authors:  Hildegard Geyer; Rudolf Geyer; Vera Pingoud
Journal:  Nucleic Acids Res       Date:  2004-09-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.